Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2005-2-24
pubmed:abstractText
Experimental studies suggest that the delivery of antiepileptic agents into the seizure focus might be of potential utility for the treatment of focal-onset epilepsies. Botulinum neurotoxin E (BoNT/E) causes a prolonged inhibition of neurotransmitter release after its specific cleavage of the synaptic protein synaptosomal-associated protein of 25 kDa (SNAP-25). Here, we show that BoNT/E injected into the rat hippocampus inhibits glutamate release and blocks spike activity of pyramidal neurons. BoNT/E effects persist for at least 3 weeks, as determined by immunodetection of cleaved SNAP-25 and loss of intact SNAP-25. The delivery of BoNT/E to the rat hippocampus dramatically reduces both focal and generalized kainic acid-induced seizures as documented by behavioral and electrographic analysis. BoNT/E treatment also prevents neuronal loss and long-term cognitive deficits associated with kainic acid seizures. Moreover, BoNT/E-injected rats require 50% more electrical stimulations to reach stage 5 of kindling, thus indicating a delayed epileptogenesis. We conclude that BoNT/E delivery to the hippocampus is both antiictal and antiepileptogenic in experimental models of epilepsy.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
23
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1943-51
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15728834-Animals, pubmed-meshheading:15728834-Anticonvulsants, pubmed-meshheading:15728834-Botulinum Toxins, pubmed-meshheading:15728834-Cell Death, pubmed-meshheading:15728834-Cognition Disorders, pubmed-meshheading:15728834-Convulsants, pubmed-meshheading:15728834-Drug Evaluation, Preclinical, pubmed-meshheading:15728834-Electric Stimulation, pubmed-meshheading:15728834-Electroencephalography, pubmed-meshheading:15728834-Epilepsies, Partial, pubmed-meshheading:15728834-Epilepsy, Generalized, pubmed-meshheading:15728834-Glutamic Acid, pubmed-meshheading:15728834-Hippocampus, pubmed-meshheading:15728834-Injections, Intralesional, pubmed-meshheading:15728834-Kainic Acid, pubmed-meshheading:15728834-Kindling, Neurologic, pubmed-meshheading:15728834-Maze Learning, pubmed-meshheading:15728834-Membrane Proteins, pubmed-meshheading:15728834-Nerve Tissue Proteins, pubmed-meshheading:15728834-Pyramidal Cells, pubmed-meshheading:15728834-Random Allocation, pubmed-meshheading:15728834-Rats, pubmed-meshheading:15728834-Rats, Long-Evans, pubmed-meshheading:15728834-Stereotaxic Techniques, pubmed-meshheading:15728834-Synaptosomal-Associated Protein 25
pubmed:year
2005
pubmed:articleTitle
Antiepileptic effects of botulinum neurotoxin E.
pubmed:affiliation
Scuola Normale Superiore, Consiglio Nazionale delle Ricerche, 56100 Pisa, Italy.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't